Marc D Lemoine

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (10)

Torsten Christ

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Harry Crijns

Maastricht University Medical Centre

NETHERLANDS

View details

Lucie Carrier

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Paulus Kirchhof

University of Birmingham

UNITED KINGDOM

View details

Moritz Nies

University Heart and Vascular Center

GERMANY

View details

Christina Magnussen

University Heart and Vascular Center Hamburg

GERMANY

View details

Edzard Schwedhelm

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Andreas Metzner

GERMANY

View details

Jussi Koivumäki

University of Tampere

FINLAND

View details

Elke Hammer

University Medicine Greifswald

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marc D Lemoine

Research Interests

Explore related searches

Contact this professor

Articles (20)

Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial

Prevalence of Heart Failure With Preserved Ejection Fraction in Patients Referred for Atrial Fibrillation Ablation

Comparison of cardiac troponin assays reveals assay-specific sensitivities in a clinical model of very acute myocardial injury

Asymptomatic atrial fibrillation: the tasks ahead

Improving antiarrhythmic therapy for patients with atrial fibrillation using common genetic variants

Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial

General anaesthesia and deep sedation for monopolar pulsed field ablation using a lattice-tip catheter combined with a novel three-dimensional mapping system

Pulmonary vein reconnection and repeat ablation characteristics following cryoballoon‐compared to radiofrequency‐based pulmonary vein isolation

Pulsed-field- vs. cryoballoon-based pulmonary vein isolation: lessons from repeat procedures

Atrial fibrillation in the young: consider heritable conditions like short QT syndrome

Acute lesion extension following pulmonary vein isolation with two novel single shot devices: Pulsed field ablation versus multielectrode radiofrequency balloon

Nonthermal Point-by-Point Pulmonary Vein Isolation Using a Novel Pulsed Field Ablation System

Pulsed-field ablation-based pulmonary vein isolation: acute safety, efficacy and short-term follow-up in a multi-center real world scenario

Pulmonary Vein Isolation by Pulsed-field Ablation Induces Less Neurocardiac Damage Than Cryoballoon Ablation

PITX2 Knockout Induces Key Findings of Electrical Remodeling as Seen in Persistent Atrial Fibrillation

<i>ACTN2</i> Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes

Regulation of APD and Force by the Na+/Ca2+ Exchanger in Human-Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue

The established and the challenger: A direct comparison of current cryoballoon technologies for pulmonary vein isolation

Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?

Human Engineered Heart Tissue Patches Remuscularize the Injured Heart in a Dose-Dependent Manner.

Collaborators (10)

Torsten Christ

Harry Crijns

Lucie Carrier

Paulus Kirchhof

Moritz Nies

Christina Magnussen

Edzard Schwedhelm

Andreas Metzner

Jussi Koivumäki

Elke Hammer

Make your next move.